Achillea millefolium (
A. millefolium) or yarrow is a member of the Asteraceae family and is used frequently as a medicinal plant worldwide for the treatment of wounds, hemorrhages headaches, inflammation, spasmodic diseases, flatulence, and dyspepsia (
1,
2). Recent research suggested that
A. millefolium might serve as a complementary therapy for the treatment of nervous system-related disorders. One study reported that
A. millefolium extract had anti-inflammatory effects in primary cultures of brain microglial cells and that it may have a role in the prevention and treatment of neurodegenerative disorders, such as Alzheimer’s disease and Parkinson’s disease (
3). Another study indicated that aqueous extract of
A. millefolium inhibited clinical scores and inflammation in an animal model of multiple sclerosis (
4). In addition, in rodent studies,
A. millefolium was reported to have anticonflict (
5) and anxiolytic properties (
6). Given the potential beneficial effects of
A. millefolium extract in the prevention or treatment of central nervous system diseases and the increase in its use, understanding possible adverse impacts of this plant on the brain is important.
The whisker barrel cortex is a discrete region in the primary somatosensory cortex of rodents that is involved in the cortical representation of whiskers. Previous research demonstrated a one-to-one relationship between vibrissae (whiskers) and specific areas of the barrel cortex, with the neurons in each barrel showing greater responses to the principal whiskers (PWs) than to several adjacent whiskers (AWs) (
7,
8). Cortical neuronal receptive fields have both excitatory and inhibitory components. These features make the whisker-barrel system a good model to study neuronal electrophysiological properties in the cortex.